Biomerica, Inc.

Biomerica, Inc.

NNASDAQ:BMRA
1.32
USD
-0.04
(-2.94%)
-1.63EPS
9.59MMarket Cap
Jan 08Next Earn

Total Valuation

USD

As of August 31, 2026, Biomerica, Inc. carries a market capitalization of 9.59M, placing it among publicly traded companies globally. Its enterprise value stands at 9.18M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap9.59M
Enterprise Value9.18M

Important Dates

Biomerica, Inc.'s next confirmed earnings release is scheduled for January 8, 2027.

Earnings Date1/8/2027

Share Statistics

As of August 31, 2026, Biomerica, Inc. has 4.59M shares outstanding.

Shares Outstanding4.59M

Valuation Ratios

These figures are as of August 31, 2026. The price-to-sales ratio is 1.48, and the price-to-book ratio stands at 2.63.

PS Ratio1.48
PB Ratio2.63
P/TBV Ratio2.78
P/FCF Ratio-1.62
P/OCF Ratio-1.62

Enterprise Valuation

These figures are as of August 31, 2026. The EV/Sales ratio of 2.12 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 9.18M versus a market cap of 9.59M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales2.12

Financial Position

As of August 31, 2026, Biomerica, Inc. maintains a current ratio of 1.91, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 63.76, indicating elevated leverage, while an interest coverage ratio of -838.83 demonstrates limited ability to service its debt obligations.

Current Ratio1.91
Quick Ratio1.28
Debt / Equity63.76
Debt / EBITDA-0.46
Interest Coverage-838.83

Financial Efficiency

USD

Over the twelve months ended August 31, 2026, Biomerica, Inc. posted a negative return on equity (ROE) of -113.80, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -67.12, reflecting losses generated across the asset base. The company generates approximately 83,403.85 in revenue per employee across its workforce of 52.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.77 indicates how many times Biomerica, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-113.80
Return on Assets (ROA)-67.12
Revenue Per Employee83,403.85
Employee Count52.00
Inventory Turnover2.77

Taxes

USD

Over the twelve months ended August 31, 2026, Biomerica, Inc. recorded 25,000.00 in income tax expense. The company reported a pretax loss of -4.98M and -5.01M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax25,000.00

Stock Price Statistics

USD

As of the close on November 16, 2026, Biomerica, Inc.'s stock has declined approximately 45.23% over the past 52 weeks. The 50-day moving average sits at 1.96, while the 200-day moving average is 2.00.

52-Week Price Change-45.23%
50-Day Moving Average1.96
200-Day Moving Average2.00

Income Statement

USD

Over the twelve months ended August 31, 2026, Biomerica, Inc. generated 4.34M in revenue and converted that into -5.01M in net income, yielding earnings per share of -1.63. EBITDA reached -5.03M, while operating income came in at -5.43M.

Revenue4.34M
Gross Profit39,000.00
Operating Income-5.43M
Pretax Income-4.98M
Net Income-5.01M
EBITDA-5.03M
EBIT-5.43M
Earnings Per Share (EPS)-1.63

Balance Sheet

USD

As of August 31, 2026, Biomerica, Inc. holds 2.73M in cash and equivalents against 2.33M in total debt, resulting in a net debt position of -2.23M. Total book value stands at 3.65M, with working capital of 2.57M providing operational flexibility.

Cash & Cash Equivalents2.73M
Total Debt2.33M
Net Debt-2.23M
Equity (Book Value)3.65M
Book Value Per Share0.79
Working Capital2.57M

Cash Flow

USD

Biomerica, Inc. produced -3.95M in operating cash flow over the twelve months ended August 31, 2026.

Operating Cash Flow-3.95M
Free Cash Flow-3.95M
FCF Per Share-1.29

Margins

Over the twelve months ended August 31, 2026, Biomerica, Inc. posted a gross margin of 0.90, reflecting its pricing power and cost economics. The operating margin of -125.22 and net profit margin of -115.49 provide insight into operational efficiency.

Gross Margin0.90
Operating Margin-125.22
Pretax Margin-114.92
Profit Margin-115.49
EBITDA Margin-116.05

Dividends & Yields

These figures cover the twelve months ended August 31, 2026. Free cash flow yield is negative at -61.62: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -38.00, meaning Biomerica, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-38.00
FCF Yield-61.62

Stock Splits

Biomerica, Inc.'s most recent stock split took place on April 21, 2025 with a 8:1 split ratio.

Last Split Date4/21/2025
Split Ratio8:1

Scores

As of August 31, 2026, Biomerica, Inc. has an Altman Z-Score of -10.39, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-10.39